highperformr logo

Stealth BioTherapeutics's Overview

Total employees33
HeadquartersNew York
Founded2006

Stealth BioTherapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction. Mitochondria, known as the powerhouse of the cell, are critical for normal organ function. Stealth's lead candidate, elamipretide, is being investigated for various rare mitochondrial diseases and other conditions with high unmet medical needs. The company aims to improve the lives of patients suffering from these debilitating conditions by targeting the underlying mitochondrial impairment.

Where is Stealth BioTherapeutics's Headquarters?

Stealth BioTherapeutics officeStealth BioTherapeutics officeStealth BioTherapeutics officeStealth BioTherapeutics office
*Images sourced via web search. Rights belong to original owners

HQ Function

Serves as the main U.S. operational base, overseeing clinical development programs, research collaborations, regulatory affairs, and corporate administration.

Notable Features:

Modern office space situated in a commercial building in Hudson Square, a neighborhood known for its mix of tech, media, and life science companies. Proximity to academic research institutions and a vibrant biotech ecosystem.

Work Culture:

A focused, science-driven, and collaborative environment. Employees are typically passionate about addressing rare diseases and driven by a patient-centric mission. As a smaller, specialized biotech, agility and innovation are key aspects of the culture.

HQ Significance:

The New York headquarters centralizes Stealth BioTherapeutics' U.S. operations, facilitating strategic decision-making and management of its clinical programs aimed at tackling mitochondrial diseases.

Values Reflected in HQ: The choice of a strategic location in a major biotech hub reflects a commitment to innovation, collaboration, and efficient operations. The focus is on advancing scientific research and development for critical unmet medical needs.

Location:

Stealth BioTherapeutics primarily conducts its research and development operations from its U.S. base. Its global presence is mainly characterized by its clinical trial activities, which may involve sites and patients in multiple countries to evaluate the efficacy and safety of its drug candidates. The company also engages with the international scientific and medical community through publications, conference presentations, and collaborations with research institutions worldwide. While its physical office footprint is concentrated, its impact and reach in the field of mitochondrial medicine are global.

Street Address:

180 Varick Street, Suite 812

City:

New York

State/Province:

NY

Country:

USA

Stealth BioTherapeutics's Global Presence

Hamilton, Bermuda

Address: Clarendon House, 2 Church Street, HM 11

Legal and corporate registration in an international financial center. Not an active R&D or primary business operations site.

Buying Intent Signals for Stealth BioTherapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Stealth BioTherapeutics

As of April 2025, Stealth BioTherapeutics' leadership includes:

Reenie McCarthy - Chief Executive Officer

Investors of Stealth BioTherapeutics

Stealth BioTherapeutics has been backed by several prominent investors over the years, including:

Morningside Venture Investments (led the going-private transaction)
Nan Fung Life Sciences (historical major investor)
Tavistock Life Sciences (historical investor)
LKF Bio-Ventures (historical investor)

Executive New Hires/Exits in the Last 12 Months

Hire0
Exits0

Following its transition to a private company in late 2022/early 2023, there have been no major publicly announced executive team changes in the last 12 months. Leadership stability under CEO Reenie McCarthy has been maintained. Detailed information on internal team adjustments is not publicly available.

Departures

N/A, No specific executive departures publicly announced in the last 12 months.

New Appointments:

N/A, No specific new executive appointments publicly announced in the last 12 months.

Technology (Tech Stack) used by Stealth BioTherapeutics

Discover the tools Stealth BioTherapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Stealth BioTherapeutics Email Formats and Examples

Stealth BioTherapeutics likely utilizes a common corporate email format. Based on publicly available information for some executives, one observed pattern is the first initial followed by the last name.

[first_initial][last]@stealthbt.com

Format

jsmith@stealthbt.com

Example

75%

Success rate

News and media

Stealth BioTherapeutics WebsiteMay 2, 2024

Stealth BioTherapeutics Presented New Elamipretide Data at the Mitochondrial Medicine 2024 Symposium

Stealth BioTherapeutics announced new data presentations on elamipretide at the Mitochondrial Medicine 2024 Symposium, hosted by the United Mitochondrial Disease Foundation. The presentations highlighted findings relevant to the treatment of primary mitochondrial disease....more

Stealth BioTherapeutics WebsiteJanuary 25, 2023

Stealth BioTherapeutics Announces Publication of Phase 2 ReCLAIM-2 Data Evaluating Elamipretide in Patients with Noncentral Geographic Atrophy and High-Risk Drusen Associated with Dry Age-Related Macular Degeneration

The company announced the publication of data from its Phase 2 ReCLAIM-2 trial in the Journal of Clinical Investigation. The trial evaluated the safety and efficacy of elamipretide in patients with dry age-related macular degeneration (AMD) with noncentral geographic atrophy and high-risk drusen....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Stealth BioTherapeutics, are just a search away.